Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Perspectum provides imaging solutions to help doctors in clinical decision-making as well as support patient engagement.
natcap is a nature intelligence company that provides report and act on impacts and dependencies on nature.
PQShield is a post-quantum cryptography company that develops cryptographic algorithms and protocols to secure technology infrastructures.
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.
Oxford Quantum Circuits develops quantum computers designed for breakthrough discoveries.
Proxisense has developed extreme environment proximity sensors and fluid contamination systems.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Oxford Ionics is a quantum computing startup that provides innovations for the development of accurate and dependable quantum computers.
Building the most advanced global infrastructure for People Science.
Covatic is the use of mobile based algorithms to bring smart personalisation to apps.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
QuantrolOx is building automated machine learning-based control software for quantum technologies to tune, stabilize, and optimize qubits.
Quantum Motion is building a universal quantum computer in Silicon, using CMOS compatible processes.
Oxford VR is an evidence-based immersive treatment for serious mental illness and behavioral health.
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
BehaVR develops evidence-based, immersive, digital therapeutics for behavioral health using Virtual Reality.
Xerion Healthcare is the technology commercialization company of University of Oxford.
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
BibliU provides colleges and universities with digital content management, automation, and an analytics platform.
Opsydia is set to disrupt a number of industries by its ability to create practically invisible structures inside transparent materials.
MiroBio is Harnessing the natural control mechanisms of the immune system.
Oxford Science Enterprises has invested in 138 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Biotechnology, Health Care, Quantum Computing, Medical, Software. The firm invests across 43 different industry categories.
Among tracked funding rounds, Amber Therapeutics received $101.8M in a Series A round. Oxford Science Enterprises's total known invested capital is $3.3B.
Oxford Science Enterprises's average investment size is $23.9M across its portfolio of 138 companies.
Recent Oxford Science Enterprises portfolio additions include Perspectum, natcap, PQShield, Amber Therapeutics, Oxford Endovascular. These companies were founded in 2020 or later.